Momo Kamei, Kazuhiko Matsuo, Yusuke Yoshida, Kaho Shimada, Mayuko Otsuki, Nao Fujimoto, Miho Ishibashi, Ying-Shu Quan, Fumio Kamiyama, Yuta Hara, et al. Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells. International journal of cancer. 2024. 154. 12. 2176-2188
Haruo Ohtani, Kazuhiko Matsuo, Kosuke Kitahata, Eiichi Sato, Takashi Nakayama. C-C Chemokine 21-Expressing T-cell Zone Fibroblastic Reticular Cells, Abundant in Lymph Nodes, Are Absent in Cancer Lymphoid Stroma. Acta histochemica et cytochemica. 2024. 57. 2. 67-74
Yuichiro Kaibori, Saho Tamoto, Sayoko Okuda, Kazuhiko Matsuo, Takashi Nakayama, Daisuke Nagakubo. CCL28: A Promising Biomarker for Assessing Salivary Gland Functionality and Maintaining Healthy Oral Environments. Biology. 2024. 13. 3
Yuta Hara, Tatsuma Honzawa, Moeka Kitagawa, Ritsuki Sano, Kazuhiko Matsuo, Takashi Nakayama. Aggravation of lipopolysaccharide-induced depressive-like behavior in CCR4-deficient mice. Journal of Pharmacological Sciences. 2023. 153. 3. 89-93
Masako Sato, Kazuhiko Matsuo, Yoko Susami, Ayaka Yamashita, Haruko Hayasaka, Yuta Hara, Keiji Nishiwaki, Naoki Oiso, Akira Kawada, Atsushi Otsuka, et al. A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells. International Immunology. 2023. 35. 9. 437-446